HK1158990A1 - Tablet quickly disintegrating in the oral cavity and method for producing the same - Google Patents

Tablet quickly disintegrating in the oral cavity and method for producing the same

Info

Publication number
HK1158990A1
HK1158990A1 HK11113851.8A HK11113851A HK1158990A1 HK 1158990 A1 HK1158990 A1 HK 1158990A1 HK 11113851 A HK11113851 A HK 11113851A HK 1158990 A1 HK1158990 A1 HK 1158990A1
Authority
HK
Hong Kong
Prior art keywords
producing
same
oral cavity
quickly disintegrating
tablet quickly
Prior art date
Application number
HK11113851.8A
Other languages
English (en)
Inventor
Toru Fukushima
Takashi Shimizu
Teruko Yoshida
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of HK1158990A1 publication Critical patent/HK1158990A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/003—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/772—Articles characterised by their shape and not otherwise provided for
    • B29L2031/7728—Disc-shaped

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK11113851.8A 2008-06-13 2011-12-22 Tablet quickly disintegrating in the oral cavity and method for producing the same HK1158990A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008155300 2008-06-13
PCT/JP2009/060584 WO2009151072A1 (ja) 2008-06-13 2009-06-10 口腔内速崩壊錠及びその製造方法

Publications (1)

Publication Number Publication Date
HK1158990A1 true HK1158990A1 (en) 2012-07-27

Family

ID=41416778

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113851.8A HK1158990A1 (en) 2008-06-13 2011-12-22 Tablet quickly disintegrating in the oral cavity and method for producing the same

Country Status (10)

Country Link
US (2) US9119820B2 (zh)
EP (1) EP2308511B1 (zh)
JP (1) JP5583012B2 (zh)
KR (1) KR101618388B1 (zh)
CN (1) CN102119034B (zh)
AU (1) AU2009258560B2 (zh)
CA (1) CA2727488C (zh)
ES (1) ES2400774T3 (zh)
HK (1) HK1158990A1 (zh)
WO (1) WO2009151072A1 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123678A1 (ja) * 2005-05-18 2006-11-23 Dainippon Sumitomo Pharma Co., Ltd. ドロキシドパを含有する安定な錠剤
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
AU2008318851B2 (en) 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
JP5420321B2 (ja) * 2009-06-22 2014-02-19 沢井製薬株式会社 ポラプレジンク含有口腔内崩壊錠
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
JP5876418B2 (ja) * 2010-12-28 2016-03-02 大鵬薬品工業株式会社 口腔内崩壊錠剤
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US20160051478A1 (en) * 2013-03-29 2016-02-25 Roquette Freres Film-forming compostions for the film-coating of solid forms
TWI673069B (zh) * 2013-07-06 2019-10-01 日商大賽璐股份有限公司 超高速崩解錠劑及其製造方法
CN104434868A (zh) * 2013-09-18 2015-03-25 重庆圣华曦药业股份有限公司 一种稳定且利于在消化道溶出的屈昔多巴口服剂型
CN103549362A (zh) * 2013-10-31 2014-02-05 潘昌仁 一种含有天门冬酰苯丙氨酸甲酯的复合甜味剂
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
KR101964546B1 (ko) * 2015-07-27 2019-04-01 유니켐 레버러토리스 리미티드 토파시티닙 경구 붕해 정제
WO2017126478A1 (ja) * 2016-01-18 2017-07-27 株式会社ダイセル 口腔内保持型崩壊性固形製剤、その製造方法、及び該製造方法に用いる粉体組成物
JP2017218445A (ja) * 2016-06-03 2017-12-14 三洋化成工業株式会社 崩壊剤用組成物及びその製造方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
EP4268815A3 (en) * 2019-04-17 2024-02-21 NordicCan A/S Fast disintegrating cannabinoid tablets
JP7145121B2 (ja) * 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法
CN110354106B (zh) * 2019-08-21 2023-03-24 成都诺和晟泰生物科技有限公司 一种在口腔中快速溶解的膜剂及其制备方法
WO2024108082A1 (en) * 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Orodispersive dosage forms containing droxidopa

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580059A5 (zh) 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JP3701990B2 (ja) 1994-08-19 2005-10-05 ピジョン株式会社 ゴオウを成分とする小児五疳薬剤
CN1222317C (zh) * 1996-07-12 2005-10-12 第一制药株式会社 可迅速崩解的压模物质及其生产方法
JPH115738A (ja) 1997-06-15 1999-01-12 Katsuhiro Nishino 脳虚血に伴う神経脱落症状の予防剤および超急性期治療剤
US6465009B1 (en) 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
EP1072264A4 (en) * 1998-04-16 2004-07-28 Ajinomoto Kk REMEDIES FOR PRIMITIVE BILIARY CIRRHOSIS
US20020177593A1 (en) 1998-09-30 2002-11-28 Yuji Ishihara Agents and crystals for improving excretory potency of urinary bladder
ATE283708T1 (de) * 1999-02-15 2004-12-15 Sumitomo Pharma Im mundraum schnellzerfallende tabletten
US20030026835A1 (en) 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
ATE437632T1 (de) 2000-03-01 2009-08-15 Eisai R&D Man Co Ltd Schnellzerfallende polyvinylhaltige tablette
WO2001076565A1 (fr) * 2000-04-12 2001-10-18 Banyu Pharmaceutical Co., Ltd. Compositions et preparations se desintegrant dans la cavite buccale
DK1327440T5 (da) 2000-09-22 2009-09-07 Dainippon Sumitomo Pharma Co Orale pr parater med gunstige nedbrydningsegenskaber
JP2002363067A (ja) * 2001-06-06 2002-12-18 Shin Etsu Chem Co Ltd 錠剤の製造方法
JP2003095928A (ja) * 2001-09-27 2003-04-03 Kowa Co 糖衣製剤
FR2841138B1 (fr) * 2002-06-25 2005-02-25 Cll Pharma Composition pharmaceutique solide contenant un principe actif lipophile, son procede de preparation
US20060105036A1 (en) 2003-05-12 2006-05-18 Stephen Peroutka Threo-dops controlled release formulation
ES2278115T3 (es) * 2003-10-13 2007-08-01 Zoser B. Nat.Rer.Dr. Salama Composicion farmaceutica que comprende oxoplatino y sus sales.
WO2006123678A1 (ja) 2005-05-18 2006-11-23 Dainippon Sumitomo Pharma Co., Ltd. ドロキシドパを含有する安定な錠剤
WO2006128022A2 (en) 2005-05-25 2006-11-30 Transcept Pharmaceuticals, Inc. Solid compositions and methods for treating middle-of-the night insomnia
CN101198327B (zh) * 2005-05-25 2012-06-20 特兰斯塞普特制药公司 治疗半夜失眠的固体组合物和方法
DK1884242T3 (da) 2005-05-26 2013-05-06 Dainippon Sumitomo Pharma Co Farmaceutisk sammensætning omfattende lurasidon
EP2050448A4 (en) * 2006-08-08 2012-01-04 Kissei Pharmaceutical Mouth-dropping tray with masked bitter taste and method of preparation

Also Published As

Publication number Publication date
US9119820B2 (en) 2015-09-01
KR20110018424A (ko) 2011-02-23
US20110105615A1 (en) 2011-05-05
ES2400774T3 (es) 2013-04-12
US20150320688A1 (en) 2015-11-12
JPWO2009151072A1 (ja) 2011-11-17
AU2009258560A1 (en) 2009-12-17
EP2308511A1 (en) 2011-04-13
CA2727488A1 (en) 2009-12-17
AU2009258560B2 (en) 2014-07-10
CN102119034A (zh) 2011-07-06
JP5583012B2 (ja) 2014-09-03
CN102119034B (zh) 2013-05-22
EP2308511B1 (en) 2012-12-26
WO2009151072A1 (ja) 2009-12-17
CA2727488C (en) 2016-09-20
AU2009258560A2 (en) 2011-02-03
KR101618388B1 (ko) 2016-05-04
EP2308511A4 (en) 2011-11-23

Similar Documents

Publication Publication Date Title
HK1158990A1 (en) Tablet quickly disintegrating in the oral cavity and method for producing the same
EP2233129A4 (en) TABLET CRUDE-BREAKING IN THE MOUTH CAVITY AND METHOD OF MANUFACTURING THE SAME
EP2270818A4 (en) POLYELECTROLYTE AND PROCESS FOR PREPARING THE POLYELECTROLYTE
EP2368544A4 (en) RAPID ORAL DELETING TABLET, AND PROCESS FOR PRODUCING THE SAME
EP2185159A4 (en) BORTEZOMIB AND MANUFACTURING METHOD THEREFOR
EP1967211A4 (en) PROCESS FOR PRODUCING SOLID PREPARATION DISINTEGRATING IN ORAL CAVITY
HK1116410A1 (en) N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
EP2244658A4 (en) METHOD AND DEVICE FOR ELECTRONIC MODELING AND MANUFACTURE OF ARTIFICIAL BITES
EP2305400A4 (en) ALUMINUM DIAMOND COMPOSITE AND METHOD OF MANUFACTURING THEREOF
PL2285870T3 (pl) Materiał i sposób jego wytwarzania
EP2264079A4 (en) COPOLYMER AND METHOD FOR PRODUCING THE SAME
ZA201009214B (en) Device and method for detecting plaque in the oral cavity
EP2243868A4 (en) LAMINATE AND MANUFACTURING METHOD THEREOF
EP1987724A4 (en) FOOD AND METHOD FOR PRODUCING A FOOD
EP2141218A4 (en) DEVICE AND METHOD FOR PRODUCING BIOKOKOS
EP2330876A4 (en) METHOD FOR PRODUCING A TRANSMITTED STRUCTURE AND DRAWER MATRIZE FOR USE FOR THE PROCESS
EP2143780A4 (en) BIOCOKE PRODUCTION EQUIPMENT AND METHOD THEREOF
EP2194100A4 (en) POLYMER ALLOY AND MANUFACTURING METHOD THEREFOR
EP2138168A4 (en) ORAL ADMINISTRATION AGENT AND METHOD FOR PRODUCING THE SAME
EP2234626A4 (en) METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION
ZA201203913B (en) Milk-beased alternative product and method for producing the same
HK1131005A1 (zh) 凝膠狀食品及其製造方法
EP2233512A4 (en) POLYTHIOETHERIMIDES AND PROCESS FOR PRODUCING THE SAME
EP2301590A4 (en) BONE REPAIR MATERIAL AND METHOD FOR PRODUCING THE SAME
HK1116725A1 (en) Pressing mold and method for producing the same